» Authors » David F Penson

David F Penson

Explore the profile of David F Penson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 566
Citations 11901
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez A, Al Hussein Al Awamlh B, Huang L, Zhao Z, Koyama T, Hoffman K, et al.
Urol Oncol . 2024 Dec; 43(4):271.e19-271.e28. PMID: 39690079
Objectives: Compare functional outcomes and treatment-related regret over 10 years in Spanish- and English-speaking Hispanic men compared to non-Hispanic men following treatment of localized prostate cancer. Methods And Materials: Data...
2.
Nguyen D, Barocas D, Zhao Z, Huang L, Koyama T, Al Hussein Ai Awamlh B, et al.
J Cancer Surviv . 2024 Oct; PMID: 39400687
Purpose: There is limited evidence of tobacco smoking's effect on cancer survivors' quality of life (QOL) and function. As the natural history of localized prostate cancer (PCa) is protracted, there...
3.
Joyce D, Boehmer K, Kamath C, LaVecchia C, Sharma V, Schulte P, et al.
Urol Pract . 2024 Jun; 11(4):640-652. PMID: 38899638
Introduction: Financial toxicity associated with treatments for metastatic prostate cancer remains poorly defined. We sought to understand aspects of financial toxicity not captured in a commonly employed financial toxicity questionnaire...
4.
Tosoian J, Penson D, Chinnaiyan A
JAMA . 2024 Apr; 331(17):1448-1450. PMID: 38581253
No abstract available.
5.
Hawkins A, Penson D, Geiger T, Bonnet K, Mutch M, Maguire L, et al.
Ann Surg . 2024 Feb; 279(5):818-824. PMID: 38318711
Objective: Understand the patient's decision-making process regarding colectomy for recurrent diverticulitis. Background: The decision to pursue elective colectomy for recurrent diverticulitis is highly preference-sensitive. Little is known about the patient's...
6.
Al Hussein Al Awamlh B, Wallis C, Penson D, Huang L, Zhao Z, Conwill R, et al.
JAMA . 2024 Jan; 331(4):302-317. PMID: 38261043
Importance: Adverse outcomes associated with treatments for localized prostate cancer remain unclear. Objective: To compare rates of adverse functional outcomes between specific treatments for localized prostate cancer. Design, Setting, And...
7.
Talwar R, Akinsola O, Penson D
BJU Int . 2024 Jan; 133(4):360-364. PMID: 38229478
Since the widespread adoption of prostate-specific antigen-based screening for prostate cancer, the prevalence of Grade Group 1 (GG1) prostate cancer has risen. Historically, these patients were subjected to overtreatment of...
8.
Ho D, Kaplan R, Bergman J, Penson D, Waterman B, Williams K, et al.
Med Care . 2023 Nov; 61(10):681-688. PMID: 37943523
Background: Previsit decision aids (DAs) have promising outcomes in improving decisional quality, however, the cost to deploy a DA is not well defined, presenting a possible barrier to health system...
9.
Yuh L, DallEra M, Penson D, Evans C
Urol Pract . 2023 Aug; 2(4):154-159. PMID: 37559259
Introduction: Active surveillance is the standard alternative to immediate curative intervention in men with low risk prostate cancer. It avoids unnecessary treatments while allowing for curative intervention in cases that...
10.
Stimson C, Resnick M, Patel S, Zaid H, Cookson M, Penson D, et al.
Urol Pract . 2023 Aug; 1(3):127-133. PMID: 37537826
Introduction: Clinical guidelines for muscle invasive bladder cancer recommend radical cystectomy with pelvic lymph node dissection as the preferred treatment, although adherence to this guideline is variable. We tested whether...